Marcos Hatada

3.1k citations

29 papers · 2.3k indexed · h-index 22

Virology top 5%
- HIV Research and Treatment 3
Immunology top 5%
Molecular Biology top 5%
- Chemical Synthesis and Analysis 5
- Protein Kinase Regulation and GTPase Signaling 5
- Protein Tyrosine Phosphatases 3
Organic Chemistry top 5%
Oncology top 10%
- Cytokine Signaling Pathways and Interactions 3
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 6
Infectious Diseases
- HIV/AIDS drug development and treatment 4
Materials Chemistry
- Enzyme Structure and Function 3

Co-authors: Bradford Graves Xiaode Lu Dennis A. Holt Carl T. Rollins Tim Clackson Michael Gilman Antonin Kröhn Sally Redshaw
Cited by: Virology Immunology Molecular Biology
Journals: Journal of Medicinal Chemistry (4 papers)Proceedings of the National Academy of Sciences (4 papers)Nature (3 papers)
Partner nations: United States Switzerland United Kingdom

In The Last Decade

Marcos Hatada

29 papers receiving 2.2k citations

Peers

Countries citing papers authored by Marcos Hatada

Since Specialization

Citations

This map shows the geographic impact of Marcos Hatada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcos Hatada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcos Hatada more than expected).

Fields of papers citing papers by Marcos Hatada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcos Hatada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcos Hatada. The network helps show where Marcos Hatada may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Marcos Hatada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marcos Hatada Line = papers co-authored together Marcos Hatada links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	In VitroCharacterization of GS-8374, a Novel Phosphonate-Containing Inhibitor of HIV-1 Protease with a Favorable Resistance Profile Antimicrobial Agents and Chemotherapy ·Christian Callebaut,Kirsten M. Stray,Luong Tsai,Antonio Henrique Barroso Do Vale Filho,Zhengyu Yang,Carina Cannizzaro,Stephanie A. Leavitt,Xiaohong Liu,Kelly Wang,Bernard P. Murray,Andrew Mulato,Marcos Hatada,T. Gaskell,Neil Parkin,S. Swaminathan,William Lee,Gong-Xin He,Lianhong Xu,Tomáš Cihlář	2011	29
2	Human immunodeficiency virus type 1 evasion of a neutralizing anti-V3 antibody involves acquisition of a potential glycosylation site in V2 Journal of General Virology ·Marcos Hatada,Kazuhisa Yoshimura,Shinji Harada,Andy Brown,Wei-fang Zhai,Sachiko Matsushita	2009	18
3	Suppression of HIV-1 Protease Inhibitor Resistance by Phosphonate-mediated Solvent Anchoring Journal of Molecular Biology ·Tomáš Cihlář,Gong-Xin He,Xiaohong Liu,James Chen,Marcos Hatada,S. Swaminathan,Martin J. McDermott,Zhengyu Yang,Andrew Mulato,Xiaowu Chen,Stephanie A. Leavitt,Kirsten M. Stray,William A. Lee	2006	47
4	A novel phosphotyrosine mimetic 4′-carboxymethyloxy-3′-phosphonophenylalanine (cpp): exploitation in the design of nonpeptide inhibitors of pp60Src SH2 domain Bioorganic & Medicinal Chemistry Letters ·Agnieszka Nowinska,Michael G. Yang,George P. Luke,William C. Shakespeare,Raji Sundaramoorthi,Yihan Wang,D. T. Johnson,Amir Hadizadeh,Shelia M. Violette,Wei Guan,Catherine Bartlett,Jeremy A. Smith,Marcos Hatada,Xiaode Lu,David C. Dalgarno,Charles J. Eyermann,Regine S. Bohacek,Tomi K. Sawyer	2001	16
5	X-ray Structure of Citrate Bound to Src SH2 Leads to a High-Affinity, Bone-Targeted Src SH2 Inhibitor Journal of Medicinal Chemistry ·Regine S. Bohacek,David C. Dalgarno,Marcos Hatada,В.П. ЄМЕЛЬЯНОВ,Berkley A. Lynch,S. Matsushita,Amir Hadizadeh,Chester A. Metcalf,Surinder S. Narula,Tomi K. Sawyer,William C. Shakespeare,Shelia M. Violette,Manfred Weigele	2001	31
6	Structure-based design and synthesis of a novel class of Src SH2 inhibitors Bioorganic & Medicinal Chemistry Letters ·John L. Buchanan,Regine S. Bohacek,George P. Luke,Marcos Hatada,Xiaode Lu,David C. Dalgarno,Surinder S. Narula,Cara Byrne,Dennis A. Holt	1999	23
7	Selective Epimerization of Rapamycin via a Retroaldol/Aldol Mechanism Mediated by Titanium Tetraisopropoxide Organic Letters ·Wu Yang,Irma KOCA-DAĞLI,Marcos Hatada,Surinder S. Narula,Leonard W. Rozamus,Киреева Е.В.,Amparo Menéndez Carrión,David C. Dalgarno,Dennis A. Holt	1999	14
8	Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor Nature ·Marcos Hatada,Xiaode Lu,Ellen R. Laird,Jeremy Green,Jay P. Morgenstern,Meizhen Lou,إبراهيم سليمان حيدرة,Emre Tunca,Mary K. Ram,Kelly Theriault,Mark J. Zoller,Jennifer L. Karas	1995	285
9	Expression, characterization and crystallographic analysis of telluromethionyl dihydrofolate reductase Acta Crystallographica Section D Biological Crystallography ·Jeffrey O. Boles,K. Lewiński,Walter Egas Romero,Marcos Hatada,Lukasz Lebioda,R. Bruce Dunlap,Jerome D. Odom	1995	6
10	Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide Structure ·Pusat Hal Ehwal Korporat,Wenceslao 1801-1873 Ayguals de Izco,S. Scarpetta,Cintia P. Septianingsih,Jeremy Green,Danilo Prestes Miagusuku,Nenchev Marin,Liisa A. Russell,Marcos Hatada,하지현,Hafid Kadi,M. Hoffmann,Thiago de Oliveira Borges	1995	44
11	Catalytic Metal Ion Binding in Enolase: The Crystal Structure of an Enolase-Mn2+-Phosphonoacetohydroxamate Complex at 2.4-.ANG. Resolution, Biochemistry ·Yongzhi Cao,Marcos Hatada,John M. Brewer,Lukasz Lebioda	1994	29
12	Structural comparisons among the short-chain helical cytokines Structure ·Denise A. Rozwarski,Angela M. Gronenborn,G. Marius Clore,J. Fernando Bazán,Andrew Bohm,Alexander Wlodawer,Marcos Hatada,P. Andrew Karplus	1994	144
13	Concepts and progress in the development of peptide mimetics Journal of Medicinal Chemistry ·Gary L. Olson,David Bolin,Mary Pat Bonner,Michael Bös,Charles M. Cook,David C. Fry,Bradford Graves,Marcos Hatada,David E. Hill	1993	213
14	Novel binding mode of highly potent HIV-proteinase inhibitors incorporating the (R)-hydroxyethylamine isostere Journal of Medicinal Chemistry ·Antonin Kröhn,Sally Redshaw,B Verano Huerta,Bradford Graves,Marcos Hatada	1991	185
15	The Three-Dimensional X-Ray Crystal Structure of HIV-1 Protease Complexed with a Hydroxyethylene Inhibitor Advances in experimental medicine and biology ·Bradford Graves,Marcos Hatada,P.-M. Braun,Mary C. Graves,Swapan Kumar Roy,Charles M. Cook,Akiko Tsukada,Joseph A. Martin,N. A. Roberts	1991	14
16	Structure of interleukin 1 .alpha. at 2.7-.ANG. resolution Biochemistry ·Bradford Graves,Marcos Hatada,Wayne A. Hendrickson,P.-M. Braun,Vincent Madison,Yoshinori Satow	1990	139
17	Microbial products. 9. Roxaticin, a new oxo pentaene antibiotic The Journal of Organic Chemistry ·Hubert Maehr,Melissa Manfroi Dal Pizzol,Ch. Crevost,K. Maguar,Marcos Hatada,L. Todaro	1989	44
18	Crystal structure of the intensely sweet protein monellin Nature ·Craig M. Ogata,Marcos Hatada,Gail E. Tomlinson,Celine Lacerda de Abreu Soares,Sung Hou Kim	1987	80
19	Three-dimensional structure of thaumatin I, an intensely sweet protein. Proceedings of the National Academy of Sciences ·Abraham M. de Vos,Marcos Hatada,H. van der Wel,Mutia Nur Arifah,A Peerdeman,Viktoria Valentinovna Kotlyarova	1985	94
20	Crystal structure of aspartame, a peptide sweetener Journal of the American Chemical Society ·Marcos Hatada,Jarmila Jancarik,Bradford Graves,Sung Hou Kim	1985	57

About Marcos Hatada

Marcos Hatada is a scholar working on Virology, Toxicology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases, having authored 29 papers that have together received 2.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), Chemical Synthesis and Analysis (5 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), HIV/AIDS drug development and treatment (4 papers), HIV Research and Treatment (3 papers), Protein Tyrosine Phosphatases (3 papers), Enzyme Structure and Function (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). The work is most often cited by research in Virology (180 citations), Immunology (454 citations), Molecular Biology (1.4k citations), Organic Chemistry (395 citations) and Oncology (353 citations). Marcos Hatada has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Bradford Graves, Xiaode Lu, Dennis A. Holt, Carl T. Rollins, Tim Clackson, Michael Gilman, Antonin Kröhn, Sally Redshaw, Leonard W. Rozamus and Lauren Stevenson. Their work appears in journals such as Journal of Medicinal Chemistry, Proceedings of the National Academy of Sciences, Nature, Journal of Molecular Biology and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact